Chronic hepatitis C in African Americans

Clinics in Liver Disease

Volumn 9, Issue 3, 2005, Pages 427-438

  Pyrsopoulos, Nikolaos ^a,b   Jeffers, Lennox ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; ALPHA2B INTERFERON; CONSENSUS INTERFERON; ERYTHROPOIETIN; INTERFERON; PEGINTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

AFRICAN AMERICAN; ALCOHOL CONSUMPTION; ALOPECIA; ANEMIA; ARMY; CLINICAL FEATURE; CLINICAL TRIAL; DRY SKIN; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; GENOTYPE; GEOGRAPHY; HEPATITIS C; HISTOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; NEUTROPENIA; OUTCOMES RESEARCH; PREVALENCE; PUBLIC HEALTH; REVIEW; SEROPREVALENCE; SINUSITIS; SOCIAL ASPECT; SOLDIER; SURVIVAL RATE; THROMBOCYTOPENIA; VIRUS TRANSMISSION; VOMITING;

AFRICAN AMERICANS; CARCINOMA, HEPATOCELLULAR; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MILITARY PERSONNEL; PREVALENCE; UNITED STATES; VETERANS;

EID: 22044445411     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2005.05.005     Document Type: Review

References (42)

1. Centers for Disease Control and Prevention Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease MMWR 47 1998 1 39
2. M.J. Alter, D. Kruszon-Moran, and O.V. Nainan The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 341 1999 556 562
3. L.B. Seeff Natural history of hepatitis C Hepatology 26 Suppl 1 1997 21S 28S
4. M.J. Alter, M. Gallagher, and T.T. Morris Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection N Engl J Med 336 1997 741 746
5. K.W. Kizer Under Secretary for Health's information letter-hepatitis C: standards for provider evaluation and testing 1998 Department of Veterans Affairs, Veterans Health Administration Washington, DC
6. Late M. Action urged to stem hepatitis C. US Med 1998;34:3,42,43
7. G.A. Roselle, C.L. Mendenhall, and L.H. Danko A four-year review of patients with hepatitis C antibody in Department of Veterans Affairs facilities Mil Med 162 1997 711 714
8. K.C. Hyams Prevalence and incidence of hepatitis C infection in the US military: a seroepidemiologic survey of 21,000 troops Am J Epidemiol 153 2001 764 770
9. L.B. Seeff, R.N. Miller, and C.S. Rabkin 45-year follow-up of hepatitis C virus infection in healthy young adults Ann Intern Med 132 2000 105 111
10. G. Mishra, C. Sninsky, and R. Roswell Risk factors for hepatitis C virus infection among patients receiving health care in a Department of Veterans Affairs hospital Dig Dis Sci 48 2003 815 820
11. M.E. Briggs, C. Baker, and R. Hall Prevalence and risk factors for hepatitis C virus infection at an urban veterans administration medical center Hepatology 34 2001 1200 1205
12. D. Pham, D. Walshe, and J. Montgomery Seroepidemiology of hepatitis B and C in an urban VA medical center [abstract] Hepatology 24 1994 236A
13. J.H. Hoofnagle Course and outcome of hepatitis C Hepatology 36 suppl 1 2002 S21 S29
14. S.A. Villano, D. Vlahov, and K.E. Nelson Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection Hepatology 29 1999 908 914
15. M. Bonacini, M.D. Groshen, and M.C. Yu Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County Am J Gastroenterol 96 2001 2438 2441
16. T.E. Wiley, J. Brown, and J. Chan Hepatitis C infection in African Americans: its natural history and histological progression Am J Gastroenterol 97 2002 700 706
17. G. Missale, R. Bertoni, and V. Lamonaca Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response J Clin Invest 98 1996 706 714
18. F. Lechner, D.K. Wong, and P.R. Dunbar Analysis of successful immune responses in persons infected with hepatitis C virus J Exp Med 191 2000 1499 1512
19. N.H. Gruner, T.J. Gerlach, and M.C. Jung Association of hepatitis C virus-specific CD8-T cells with viral clearance in acute hepatitis C J Infect Dis 181 2000 1528 1536
20. K. Sugimoto, F. Ikeda, and J. Stadanlick Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection Hepatology 38 2003 1437 1448
21. D.M. Parkin, F. Bray, and J. Ferlay Estimating the world cancer burden: GLOBOCAN 2000 Int J Cancer 94 2001 153 156
22. P.A. Smith, A.S. Klein, and D.G. Heath Dual-phase spiral angiography with volumetric 3D rendering for preoperative liver transplant evaluation: preliminary observations J Comput Assist Tomogr 22 1998 868 874
23. H.B. El-Serag, J.A. Davila, and N.J. Petersen The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update Ann Intern Med 139 2003 817 823
24. A.M. Di Bisceglie Malignant neoplasms of the liver E.R. Schiff M.F. Sorrell W.C. Maddrey Schiff's disease of the liver 8th edition 1999 Lippincott-Raven Philadelphia 1281 1304
25. E.C. Seaberg, S.H. Belle, and K.C. Beringer Liver transplantation in the United States from 1987-1998: updated results from the Pitt-UNOS Liver Transplant Registry J.M. Cecka P.I. Terasaki Clinical transplants 1998 1998 UCLA Tissue Typing Laboratory Los Angeles (CA) 17 37
26. L.M. Forman, J.D. Lewis, and J.A. Berlin The association between hepatitis C infection and survival after orthotopic liver transplantation Gastroenterology 122 2002 889 896
27. M. Charlton, E. Seaberg, and R. Wiesner Predictors of patient and graft survival following liver transplantation for hepatitis C Hepatology 28 1998 823 830
28. A. Regev, K.R. Reddy, and M. Torres Racial differences in outcome of liver transplantation in patients with HCV cirrhosis [abstract] Hepatology 32 2000 259A
29. K.R. Reddy, J.H. Hoofnagle, and M.J. Tong Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group Hepatology 30 1999 787 793
30. J.L. Kinzie, P.H. Naylor, and M.G. Nathani African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians J Viral Hepat 8 2001 264 269
31. J.G. McHutchison, T. Poynard, and S. Pianko The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C Gastroenterology 119 2000 1317 1323
32. M.P. Manns, J.G. McHutchison, and S.C. Gordon Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 2001 958 965
33. Schering corporation supplemental submissions on peginterferon alfa 2-b and ribavirin combination therapy for chronic hepatitis C 2001 Food and Drug Administration Center for Biologics Evaluation and Research Rockville (MD)
34. M.W. Fried, M.L. Shiffman, and K.R. Reddy Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 2002 975 982
35. L.J. Jeffers, W. Cassidy, and C.D. Howell Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1 Hepatology 39 2004 1702 1708
36. A.J. Muir, J.D. Bornstein, and P.G. Killenberg Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic Caucasians N Engl J Med 350 2004 2265 2271
37. I. Jacobson, R. Brown Jr, and J. McCone Weight based ribavirin dosing improves virologic response in HCV-infected genotype 1 African Americans (AA) compared to flat dose ribavirin with peginterferon alfa-2b combination therapy [asbtract] Hepatology 40 2004 217A
38. M.L. Shiffman, A.M. Di Bisceglie, and K.L. Lindsay Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment Gastroenterology 126 2004 1015 1023
39. J.E. Layden-Almer, R.M. Ribeiro, and T. Wiley Viral dynamics and response differences in HCV-infected African American and Caucasian patients treated with IFN and ribavirin Hepatology 37 2003 1343 1350
40. G.N. Ioannou, J.A. Dominitz, and N.S. Weiss Racial differences in the relationship between hepatitis C infection and iron stores Hepatology 37 2003 795 801
41. C.L. Thio, D.L. Thomas, and J.J. Goedert Racial differences in HLA class II associations with hepatitis C virus outcomes J Infect Dis 184 2001 16 21
42. P. Kimball, R.K. Elswick, and M. Shiffman Ethnicity and cytokine production gauge response of patients with hepatitis C to interferon- alpha therapy J Med Virol 65 2001 510 516